Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Watchful Waiting × Lymphoid × Clear all

Phase

Phase 2 3 Phase 4 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1 Gynecologic 1 Genitourinary 1

Conditions

Lymphoma 1 Hodgkin Disease 1

Interventions

Cyclophosphamide 22 Vincristine 20 Rituximab 19 Methotrexate 19 Dexamethasone 19 Cytarabine 18 Mercaptopurine 15 Doxorubicin 12 Asparaginase 11 Daunorubicin 10 Granulocyte Colony-Stimulating Factor 9 Etoposide 9 Prednisone 8 Prednisolone 8 fludarabine 7 Ifosfamide 7 Idarubicin 7 Thioguanine 6 Teniposide 6 pegylated granulocyte colony-stimulating factor 4 fludarabine phosphate 4 Vindesine 4 Stem Cell Transplantation 4 Brentuximab Vedotin 4 Aprepitant 4 zanubrutinib 3 prednylidene 3 pegfilgrastim 3 ibrutinib 3 entecavir 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01088750 2023-12-13

EuroNetLP1

Martin-Luther-Universität Halle-Wittenberg

Phase 4 Completed

Hodgkin Disease, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡